Vigorous HIV-1-specific CD4(+) T cell responses associated with control of viremia

被引:1557
作者
Rosenberg, ES
Billingsley, JM
Caliendo, AM
Boswell, SL
Sax, PE
Kalams, SA
Walker, BD
机构
[1] MASSACHUSETTS GEN HOSP, PARTNERS AIDS RES CTR, BOSTON, MA 02114 USA
[2] MASSACHUSETTS GEN HOSP, INFECT DIS UNIT, BOSTON, MA 02114 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA 02114 USA
[4] MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA
[5] FENWAY COMMUNITY HLTH CTR, BOSTON, MA 02115 USA
[6] BRIGHAM & WOMENS HOSP, DIV INFECT DIS, BOSTON, MA 02115 USA
关键词
D O I
10.1126/science.278.5342.1447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Virus-specific CD4(+) T helper lymphocytes are critical to the maintenance of effective immunity in a number of chronic viral infections, but are characteristically undetectable in chronic human immunodeficiency virus-type 1 (HIV-1) infection. In individuals who control viremia in the absence of antiviral therapy, polyclonal, persistent, and vigorous HIV-1-specific CD4(+) T cell proliferative responses were present, resulting in the elaboration of interferon-gamma and antiviral beta chemokines. In persons with chronic infection, HIV-1-specific proliferative responses to p24 were inversely related to viral load. Strong HIV-1-specific proliferative responses were also detected following treatment of acutely infected persons with potent antiviral therapy. The HIV-1-specific helper cells are likely to be important in immunotherapeutic interventions and vaccine development.
引用
收藏
页码:1447 / 1450
页数:4
相关论文
共 42 条
[1]   Die and let live: Eliminating dangerous lymphocytes [J].
Abbas, AK .
CELL, 1996, 84 (05) :655-657
[2]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[3]   ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE [J].
BATTEGAY, M ;
MOSKOPHIDIS, D ;
RAHEMTULLA, A ;
HENGARTNER, H ;
MAK, TW ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4700-4704
[4]   ANTIGENIC PEPTIDES RECOGNIZED BY LYMPHOCYTES-T FROM AIDS VIRAL ENVELOPE-IMMUNE HUMANS [J].
BERZOFSKY, JA ;
BENSUSSAN, A ;
CEASE, KB ;
BOURGE, JF ;
CHEYNIER, R ;
LURHUMA, Z ;
SALAUN, JJ ;
GALLO, RC ;
SHEARER, GM ;
ZAGURY, D .
NATURE, 1988, 334 (6184) :706-708
[5]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[6]   INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
BERNSTEIN, DC ;
MANN, DL ;
SHEARER, GM ;
BERZOFSKY, JA .
NATURE, 1989, 339 (6223) :383-385
[7]   ROLE OF INTERLEUKIN-10 IN T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC INDIVIDUALS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
CLERICI, M ;
WYNN, TA ;
BERZOFSKY, JA ;
BLATT, SP ;
HENDRIX, CW ;
SHER, A ;
COFFMAN, RL ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :768-775
[8]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[9]   HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J].
Connors, M ;
Kovacs, JA ;
Krevat, S ;
GeaBanacloche, JC ;
Sneller, MC ;
Flanigan, M ;
Metcalf, JA ;
Walker, RE ;
Falloon, J ;
Baseler, M ;
Stevens, R ;
Feuerstein, I ;
Masur, H ;
Lane, HC .
NATURE MEDICINE, 1997, 3 (05) :533-540
[10]   THE EVALUATION OF LIMITING DILUTION ASSAYS [J].
DESTGROTH, SF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 49 (02) :R11-R23